# Framework reviews (2026): GLP-1 telehealth sellers | This GLP

A figure quoted by the week reads cheaper than the same money quoted by the month.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/reviews/framework
Updated: 2026-10-28

By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Quoted weekly, paid monthly

# Framework review

A figure quoted by the week reads cheaper than the same money quoted by the month.

## The verdict

Framework advertises GLP-1 treatment from $25 a week and states there are no membership fees. A year of those charges totals $1,300, which across twelve calendar months is $108.33 rather than the $100 a weekly headline invites.

**Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures).

Category

GLP-1 telehealth

Molecule

Semaglutide · Tirzepatide

Form

Injection

From

From $108.33/mo

Prescription

Required

Compounded

Yes — not FDA-approved

Framework describes itself as a precision wellness platform. Compounded semaglutide and compounded tirzepatide sit inside a wider longevity offer rather than making up the whole catalog.

1.  ## Who writes the prescription, and what do they see?
    
    US-licensed clinicians are named as the source of treatment, and a prescription comes before any shipment. Past that, the pages describe the platform rather than the clinical relationship. Nothing states what a clinician examines, or when they look again.
    
    The proposition is one clear price with no membership, repeated across the homepage rather than expanded anywhere. What the weekly charge covers beyond the drug is left unsaid, so a reader cannot tell whether supplies and delivery sit inside it.
    
2.  ## What happens when the dose goes up?
    
    No milligram quantity appears next to the weekly rate. That absence bites hardest across the first four months, when the dose normally climbs several times. Without a starting quantity there is nothing to check the price against, and Framework does not say whether the rate survives an escalation.
    
3.  ## What the price includes
    
    Multiplying by four is the error a weekly price invites. An average calendar month holds 4.33 weeks, so $25 a week is $108.33, and six months is $650. Framework also applies one rate to a single agonist and a dual agonist alike, which is not how the category usually prices them, and no explanation appears.
    
4.  ## What it claims, and what it cites
    
    Both lines are compounded preparations rather than manufactured products. The pharmacy preparing them is not identified. A compounded preparation is not reviewed by the FDA before it is dispensed.
    

## Where it holds up, and where it does not

-   Strength: Framework prints the weekly rate itself
-   Strength: No membership charge, stated plainly
-   Strength: One rate spans both molecules
-   Limitation: A weekly figure understates the calendar month
-   Limitation: No milligram quantity beside the price
-   Limitation: Silent on what happens as the dose rises
-   Limitation: The compounding pharmacy goes unnamed

## What the evidence says about this kind of treatment

The assessment above is about Framework. These are about the drugs it sells, and they are traced to the primary literature.

-   [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1)
-   [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1)
-   [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain)

Right for

A buyer who multiplies by 4.33 before shortlisting anything.

Wrong for

A buyer who needs a milligram quantity behind a figure.

## The evidence behind what Framework prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

-   [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review)
    
    A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
    
-   [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better)
    
    In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
    

## How Framework compares

| Seller | Who it suits | Go |
| --- | --- | --- |
| Rivas Medical Weight Loss | Buyers within reach of a clinic who want a clinician present every week |  |
| RxPepsDirect | Buyers at a starting dose who want per-vial pricing and no subscription |  |
| HeliMeds | Buyers converting a twelve-week plan into calendar months before comparing it |  |

[Compare all providers side by side →](https://thisglp.com/best)

More GLP-1 telehealth sellers reviews: [Synergy Rx](https://thisglp.com/reviews/synergy-rx) [T2D.com](https://thisglp.com/reviews/t2d) [TD Tele-Doc Weight Loss](https://thisglp.com/reviews/td-teledoc) [TeleCareSpot](https://thisglp.com/reviews/telecarespot) [TeleClinic](https://thisglp.com/reviews/teleclinic) [TeleDocs360](https://thisglp.com/reviews/teledocs360)

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

## Frequently asked

What does the weekly rate come to in a month?

$108.33. A calendar month averages 4.33 weeks rather than four, and the annual total is $1,300.

Is a dose published?

No milligram quantity appears beside the rate on any page.

Why do both molecules cost the same?

Framework applies one weekly figure to semaglutide and tirzepatide. Nothing published accounts for the equivalence.

Is Framework expensive compared with other GLP-1 telehealth sellers?

Framework publishes a starting figure of $108.33/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Framework below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Or [compare every seller we cover](https://thisglp.com/best).

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).
